“Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 ” (2016) The Review of Diabetic Studies, 13(4). Available at: https://diabeticstudies.org/index.php/RDS/article/view/93 (Accessed: 13 September 2025).